Peptide Therapeutics Market Regional Analysis

North America is estimated to secure the top spot when it comes to the peptide therapeutics market. Increasing incidence of chronic diseases and high investments in medical research are forecasted to be the key factors contributing to the dominance of this region. Presence of key pharmaceutical manufacturers, rising awareness regarding benefits of peptide therapeutics, and supportive government funding to boost medical R&D are also expected to bolster sales of peptide therapeutics in this region. The United States is projected to lead the demand for peptide therapeutics in North America followed by Canada.

Rising investments in healthcare infrastructure development and growing demand for novel treatments are slated to make the Asia Pacific region the fastest growing market for peptide therapeutics companies. The rowing popularity of targeted therapies, use of advanced healthcare technologies, and presence of key contract manufacturing organizations in this region are expected to help boost sales of peptide therapeutics in this region. India, China, Japan, and South Korea are projected to be the most opportune countries for peptide therapeutics providers in this region.